D N (Israel) Probability of Target Price Finishing Over Current Price

    DNA -- Israel Stock  

    ILS 28.50  0.60  2.15%

    D N probability of target price tool provides mechanism to make assumptions about upside and downside potential of D N A Biomedical Solutions Ltd performance during a given time horizon utilizing its historical volatility. Please specify D N time horizon, a valid symbol (red box) and a target price (blue box) you would like D N odds to be computed. Additionally see Investing Opportunities.
    Horizon     30 Days    Login   to change
    Refresh Odds

    D N Target Price Odds to finish over

    Current PriceHorizonTarget PriceOdds to move above current price in 30 days
     28.50 30 days 28.50  ABOUT 18.19%
    Based on normal probability distribution, the odds of D N to move above current price in 30 days from now is about 18.19% (This D N A Biomedical Solutions Ltd probability density function shows the probability of D N Stock to fall within a particular range of prices over 30 days) .
    Assuming 30 trading days horizon, D N A Biomedical Solutions Ltd has beta of -0.6827 suggesting as returns on benchmark increase, returns on holding D N are expected to decrease at a much smaller rate. During bear market, however, D N A Biomedical Solutions Ltd is likely to outperform the market. Additionally The company has an alpha of 0.4993 implying that it can potentially generate 0.4993% excess return over DOW after adjusting for the inherited market risk (beta).
     D N Price Density 
    Alpha over DOW
    Beta against DOW=0.68
    Overall volatility
    Information ratio =0.09

    D N Alerts

    D N Alerts and Suggestions

    D N A is not yet fully synchronised with the market data
    D N A has high likelihood to experience some financial distress in the next 2 years
    The company has accumulated zero balance in total debt. D N A has Current Ratio of 0.03 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
    The entity reported revenue of . Net Loss for the year was (64.93M).
    DNA BIOMED SOLUT has accumulated about 439K in cash with (2.64M) of positive cash flow from operations.

    Price Density Drivers

    D N Health Indicators

    Float Shares103.57M
    Average Daily Volume Last 10 Day465.75k
    Average Daily Volume In Three Month575.53k
    Additionally see Investing Opportunities. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
    Search macroaxis.com